Partial
Partially Aligned
Patient Risk:
Low
Summary
The evaluation correctly recognizes the labeled one-drop, four-times-daily regimen, but its proposed corrections overstate what the supplied label says about shaking the bottle and adult-specific dosing. Its pediatric-labeling note is not verifiable from the supplied sections.
Category Scores
Accurate Statements
Section 2.1 recommends one drop four times daily.
Section 2.1 directs instilling one drop of MIEBO four times daily into affected eye(s).
Unsupported Statements
Section 2.2 directs users to invert the bottle and shake it once before each use.
Section 2.2 describes squeezing the upright bottle, turning it upside down while releasing pressure, and then squeezing again to release a drop. It does not instruct users to shake the bottle.
The claim that adults use the regimen is supported by the label and does not imply an adult-only regimen.
The supplied dosage section specifies one drop four times daily into affected eye(s), but does not identify an adult population or provide an age-specific regimen. The original partial-support classification is more cautious.
FDA labeling states that pediatric safety and effectiveness have not been established (section 8.4).
Section 8.4 is not among the supplied label sections, so this statement cannot be verified against the provided prescribing information.
Contradictions
Important Omissions
The evaluation should state that the supplied administration instructions describe a specific squeeze-and-invert procedure, not shaking, and do not provide an adult-specific dosage.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Low
The errors concern how the evaluation characterizes administration instructions and the population specified for the dosage. The supplied label does not direct shaking, but the evaluation does not make a direct patient-specific dosing recommendation.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Moderate |
Recommendation
Partially Aligned
Primary Issue
The proposed correction about shaking the bottle is not supported by the supplied administration instructions, and the label does not establish an adult-specific regimen.
Suggested Improvement
Correct the shake classification to absent from the supplied label, retain the adult-dose claim as only partially supported, and avoid the pediatric-labeling assertion unless the relevant section is provided.